Big Pharma Blurring the Lines with Big Biotech; Novartis International AG (Jobs), Abbott Laboratories (Jobs), Wyeth (Jobs), Bristol-Myers Squibb Company (Jobs) Hedging Their Bets with Biotech drugs; Less Vulnerability to Generics

NEW YORK (CNNMoney.com) -- Big Pharma is starting to look more like Big Biotech.The word “biotech” makes most people think of industry leaders Amgen (down $0.02 to $54.55, Charts, Fortune 500) and Genentech (down $0.10 to $77.54, Charts). But now large pharmaceutical companies are aggressively branching into biotech. Some drugmakers -- like Novartis (up $0.04 to $56.12, Charts) and Wyeth (down $0.46 to $57.71, Charts, Fortune 500) -- have diversified so much that they’ve effectively become pharma-biotech hybrids.